Literature DB >> 6256161

Myocardial beta-adrenergic receptors from adrenalectomized rats: impaired formation of high-affinity agonist-receptor complexes.

A O Davies, A De Lean, R J Lefkowitz.   

Abstract

Adrenal steroid hormones potentiate beta-adrenergic actions on the heart. Accordingly, we investigated the effects of adrenalectomy on agonist and antagonist interactions with myocardial beta-adrenergic receptors and adenylate cyclase. The affinity and number of beta-adrenergic receptor sites, both defined by the antagonist (-) [3H]dihydroalprenolol, did not change after adrenalectomy. Computer modelling of agonist (-)-isoproterenol competition curves indicated the presence of two discrete receptor states with high and low affinities. After adrenalectomy, the agonist curves were shifted to the right, and the dissociation constant of the high-affinity state significantly rose from 12 to 48 nM (p < .001), but the dissociation constant of the low affinity state was unchanged. Although basal, maximal isoproterenol-stimulated and fluoride-stimulated adenylate cyclase activities were unaltered, the EC50 for isoproterenol stimulation was increased significantly from 490 to 1500 nM (p <.018). These results suggest that adrenal steroid hormones may regulate the ability of the beta-adrenergic receptors to form a high-affinity "coupled" state, presumably by modulating the interaction of the receptor with nucleotide regulatory proteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6256161     DOI: 10.1210/endo-108-2-720

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

Review 1.  Interactions between corticosteroids and beta agonists.

Authors:  D R Taylor; R J Hancox
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 2.  Interactions between corticosteroids and beta2-agonists.

Authors:  Robert J Hancox
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

3.  Effect of 1,25-dihydroxyvitamin D3 on cyclic AMP responses to hormones in clonal osteogenic sarcoma cells.

Authors:  M Kubota; K W Ng; T J Martin
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

4.  Loss of high affinity cardiac beta adrenergic receptors in dogs with heart failure.

Authors:  D E Vatner; S F Vatner; A M Fujii; C J Homcy
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

5.  Chloride permeability regulation via a cyclic AMP pathway in cultured human sweat duct cells.

Authors:  P S Pedersen
Journal:  J Physiol       Date:  1990-02       Impact factor: 5.182

6.  Regulation of beta-adrenergic receptors by "permissive" hormones: glucocorticoids increase steady-state levels of receptor mRNA.

Authors:  J R Hadcock; C C Malbon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Impaired formation of beta-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism.

Authors:  J A Heinsimer; A O Davies; R W Downs; M A Levine; A M Spiegel; M K Drezner; A De Lean; K A Wreggett; M G Caron; R J Lefkowitz
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

8.  The effects of hydrocortisone on rat heart muscarinic and adrenergic alpha 1, beta 1 and beta 2 receptors, propranolol-resistant binding sites and on some subsequent steps in intracellular signalling.

Authors:  Jaromír Myslivecek; Jan Rícný; Frantisek Kolár; Stanislav Tucek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-17       Impact factor: 3.000

9.  Steroid hormone modulation of cAMP production in response to beta adrenergic receptor stimulation in genital tract myocytes.

Authors:  L DiGiovanni; R Austin; M Phillippe
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

10.  Modulation of adrenal cell functions by cadmium salts: 3. Sites affected by CdCl2 during stimulated steroid synthesis.

Authors:  O P Mgbonyebi; C T Smothers; J J Mrotek
Journal:  Cell Biol Toxicol       Date:  1994-02       Impact factor: 6.691

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.